EFFECTS OF 6 WEEKS OF TREATMENT WITH DAPAGLIFLOZIN, A SODIUM-GLUCOSE COTRANSPORTER 2 INHIBITOR, ON MYOCARDIAL FUNCTION AND METABOLISM IN TYPE 2 DIABETES PATIENTS: A RANDOMIZED PLACEBO-CONTROLLED STUDY
2020
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
3
Citations
NaN
KQI